check_circleStudy Completed
Multiple Sclerosis
Bayer Identifier:
308100
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
"BRIGHT" (Betaferon® vs. Rebif® Investigating Higher Tolerability) Observational Study to assess Injection Site Pain in Multiple Sclerosis patients
Trial purpose
Please see attached Study Results Summary below.
Key Participants Requirements
Sex
N/AAge
N/ATrial summary
Enrollment Goal
454Trial Dates
June 2004 - February 2006Phase
N/ACould I Receive a placebo
N/AProducts
Betaseron (Interferon beta-1b, BAY86-5046)Accepts Healthy Volunteer
N/AWhere to participate
Status | Institution | Location |
---|---|---|
Primary Outcome
Secondary Outcome
Trial design
Trial Type
ObservationalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A